Astellas Pharma GmbH divests German and Austrian assets

Paolo Bossi

Jones Day has advised Astellas Pharma GmbH in its divestiture of certain German and Austrian Rx and OTC product assets. Jones Day advised Astellas Pharma GmbH…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here